Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression Read More > March 29, 2021
Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes Read More > March 23, 2021
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action Read More > March 19, 2021
Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer Read More > March 18, 2021
Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review Read More > March 7, 2021
Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property Read More > February 26, 2021
Functional connectivity between the amygdala and subgenual cingulate gyrus predicts the antidepressant effects of ketamine in patients with treatment-resistant depression Read More > February 21, 2021
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder Read More > February 18, 2021
Single, Fixed-Dose Intranasal Ketamine for Alleviation of Acute Suicidal Ideation. An Emergency Department, Trans-Diagnostic Approach: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial Read More > February 14, 2021
What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review Read More > February 11, 2021
